| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.18B | +6.5% |
| Cost of Revenue | $1.76B | +5.9% |
| Gross Profit | $1.43B | +7.1% |
| R&D Expense | $144.6M | +11.8% |
| SG&A Expense | $705.8M | +13.5% |
| Operating Income | $577.9M | -0.7% |
| Interest Expense | $67.5M | +81.9% |
| Pre-tax Income | $527.4M | -1.2% |
| Income Tax | $126.1M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $204.5M | -64.3% |
| Accounts Receivable | $514.8M | +7.0% |
| Inventory | $346.0M | +20.6% |
| Current Assets | $1.39B | -6.3% |
| Total Assets | $4.34B | -0.1% |
| Current Liabilities | $929.9M | -0.4% |
| Long-term Debt | $2.59B | +0.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $321.2M | -33.2% |
| Capital Expenditures | $60.0M | +25.5% |
| Investing Cash Flow | -$329.9M | +67.3% |
| Financing Cash Flow | -$347.9M | -148.0% |
| Free Cash Flow | $261.2M | -39.7% |
| +4.2% |
| Net Income | $401.3M | -2.8% |
| EPS (Basic) | $2.50 | +2.5% |
| EPS (Diluted) | $2.49 | +2.5% |
| Total Liabilities |
| $3.76B |
| -0.3% |
| Stockholders' Equity | $576.5M | +1.2% |